Laura Ibanez, a postdoctoral research associate in neurogenetics and informatics in the laboratory of Carlos Cruchaga at the School of Medicine, has received a $281,370 grant from the Alzheimer’s Drug Discovery Foundation to study gene products associated with Alzheimer’s disease that can be found in the blood. The project will use next-generation sequencing to measure gene products known as cell-free ribonucleic acids (cfRNA) in the blood of Alzheimer’s patients, pre-symptomatic patients and cognitively normal individuals, to create novel prognostic and diagnostic models of Alzheimer’s disease risk and age at onset.
A coalition of philanthropists, including Bill Gates, Jeff Bezos and Leonard A. Lauder, created the Alzheimer’s Drug Discovery Foundation in 2018. They have committed to funding nearly $50 million in research to improve Alzheimer’s treatments.
Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum.